EquityZen Growth Technology Fund LLC - Series 1514 (CIK: 0001950540) EDGAR, Information, Filings... CompaniesBIO.Com

EquityZen Growth Technology Fund LLC - Series 1514

Mailing address
6510 S MILLROCK DRIVE, SUITE 400, SALT LAKE CITY, Delaware, 84121
Phone
(801) 419-0677
State location
Utah
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

EquityZen Growth Technology Fund LLC - Series 1514 (CIK: 0001950540) is an American company incorporated in the state of Utah. Head office is located at 6510 S MILLROCK DRIVE, SUITE 400, SALT LAKE CITY, Utah, 84121. Work in the industry N/A. EquityZen Growth Technology Fund LLC - Series 1514 is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by EquityZen Growth Technology Fund LLC - Series 1514

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0001950540-22-000002 (33 Act) Size: KB	Dec-07-2022	021-466824 221450304

Recent 20 filings. View all EquityZen Growth Technology Fund LLC - Series 1514 filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

EquityZen Growth Technology Fund LLC - Series 1514 overview
EquityZen Growth Technology Fund LLC - Series 1514 job
EquityZen Growth Technology Fund LLC - Series 1514 stock
EquityZen Growth Technology Fund LLC - Series 1514 ownership
EquityZen Growth Technology Fund LLC - Series 1514 CEO
EquityZen Growth Technology Fund LLC - Series 1514 documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.